Dermatology pp 279-303 | Cite as

Pharmacology and Drug Reactions

  • Sima Jain
Chapter

Abstract

Binds and inactivates bacterial enzymes (PCN-binding proteins) involved in peptidoglycan synthesis → inhibits bacterial cell wall synthesis

Keywords

Warfarin Theophylline Erythromycin Thalidomide Itraconazole 

References

  1. 1.
    Adams DR. Adverse drug reactions in the skin. In: Schwarzenberger K, Werchniak AE, Ko CJ, eds.Requisites in Dermatology: General Dermatology. Philadelphia, PA: Elsevier Ltd; 2009:365-388.CrossRefGoogle Scholar
  2. 2.
    Akamatsu H, Zouboulis CC, Orfanos CE. Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5-dihydrotestosterone in vitro.J Investig Dermatol. 1993;100:660-662.PubMedCrossRefGoogle Scholar
  3. 3.
    Armstrong AW. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Schwarzenberger K, Werchniak AE, Ko CJ, eds.Requisites in Dermatology: General Dermatology. Philadelphia, PA: Elsevier Ltd; 2009:23-28.CrossRefGoogle Scholar
  4. 4.
    Badalementi S, Kerdel F. Azathioprine. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:165-179.Google Scholar
  5. 5.
    Braiteh F, Kurzrock R. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.J Clin Oncol. 2008;26(20):3460-3462.PubMedCrossRefGoogle Scholar
  6. 6.
    Burgin S, Wolverton SE, Callen JP. Cutaneous drug eruptions. In: Callen JP, Jorizzo JL, eds.Dermatological Signs of Internal Disease. 4th ed. Philadelphia, PA: Elsevier Ltd; 2009:401-410.CrossRefGoogle Scholar
  7. 7.
    Callen JP, Camisa C. Antimalarial agents. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:251-268.Google Scholar
  8. 8.
    Callen JP, Kulp-Shorten CL, Wolverton SE. Methotrexate. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:147-164.Google Scholar
  9. 9.
    Del Rosso JQ. Topical chemotherapy for the treatment of skin cancer. In: Rigel DS et al., eds.Cancer of the Skin. Philadelphia, PA: Elsevier Saunders Inc; 2005:619-630.Google Scholar
  10. 10.
    Evans TY, Vander Straten MR, Carrasco DA, Carlton S, Tyring SK. Systemic antiviral agents. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:85-108.Google Scholar
  11. 11.
    French LE, Prins C. Toxic epidermal necrolysis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:323-330.Google Scholar
  12. 12.
    Gollnick H. Systemic Therapy. In: Burgdorf WH, Plewig G, Wolff HH, Ladthaler M, eds.Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009:1573-1593.CrossRefGoogle Scholar
  13. 13.
    Gordon KB, West DP. Biologic therapy in dermatology. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:928-942.Google Scholar
  14. 14.
    Greaves MW. Antihistamines. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:360-374.Google Scholar
  15. 15.
    Gupta AK. Systemic antifungal agents. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:55-84.Google Scholar
  16. 16.
    Holzle E. Physical therapy: light, cold, heat. In: Burgdorf WH, Plewig G, Wolff HH, Ladthaler M, eds.Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009:1593-1608.Google Scholar
  17. 17.
    Honigsmann H, Schwarz T. Ultraviolet light therapy. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:2109-2119.Google Scholar
  18. 18.
    Knowles SR, Shear NH. Drug hypersensitivity syndromes. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:872-884.Google Scholar
  19. 19.
    Kuenzli S, Saurat JH. Retinoids. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:1991-2006.Google Scholar
  20. 20.
    Kufe DW, Pollock RE, Weichselbaum RR, et al.Holland-Frei Cancer Medicine. 6th ed. Hamilton, ON: BC Decker Inc; 2003.Google Scholar
  21. 21.
    Levy SB. Sunscreens. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:632-646.Google Scholar
  22. 22.
    Lipp HP, ed.Anticancer Drug Toxicity: Prevention, Management, and Clinical Pharmacokinetics. New York, NY: Marcel Dekker Inc; 1999:263-270.Google Scholar
  23. 23.
    Malvasi A, Tinelli A, Buia A, DeLuca GF. Possible long-term teratogenic effect of isotretinoin in pregnancy.Eur Rev Med Pharmacol Sci. 2009;13:393-396.PubMedGoogle Scholar
  24. 24.
    Mockenhaupt M. Severe cutaneous adverse reactions. In: Burgdorf WH, Plewig G, Wolff HH, Ladthaler M, eds.Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009:473-484.CrossRefGoogle Scholar
  25. 25.
    Nesbitt LT. Glucocorticoids. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:1979-1986.Google Scholar
  26. 26.
    Nguyen EQ, Wolverton SE. Systemic retinoids. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:269-310.Google Scholar
  27. 27.
    Perry MC.The Chemotherapy Source Book. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:148-152.Google Scholar
  28. 28.
    Reed BR. Dermatologic drugs during pregnancy and lactation. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:817-847.Google Scholar
  29. 29.
    Revus J, Valeyrie-Allanore L. Drug reactions. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:333-351.Google Scholar
  30. 30.
    Sadick N. Systemic antibacterial agents. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:28-54.Google Scholar
  31. 31.
    Shapiro LE, Knowles SR, Shear N. Drug-drug interactions. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:2085-2110.Google Scholar
  32. 32.
    Shapiro LE, Shear NH. Drug interactions. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:848-871.Google Scholar
  33. 33.
    Teitelbaum JE, Perez-Atayde AR, Cohen M, Bousvaros A, Jonas MM. Minocycline-related autoimmune hepatitis.Arch Pediatr Adolesc Med. 1998;152:1132-1136.PubMedGoogle Scholar
  34. 34.
    Tope WD, Shaffer JJ. Photodynamic therapy. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:2127-2140.Google Scholar
  35. 35.
    Wolverton SE, Callen JP. Cutaneous drug eruptions. In: Callen JP, Jorizzo JL, Bolognia JL, Piette WW, Zone JJ, eds.Dermatological Signs of Internal Disease. 3rd ed. Philadelphia, PA: Elsevier Science Ltd; 2003:343-351.Google Scholar
  36. 36.
    Wolverton SE, Callen JP. Systemic therapy for cutaneous disease. In: Callen JP, Jorizzo JL, eds.Dermatological Signs of Internal Disease. 4th ed. Philadelphia, PA: Elsevier Inc; 2009:411-414.CrossRefGoogle Scholar
  37. 37.
    Wolverton SE. Systemic Corticosteroids. In: Wolverton SE, ed.Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: W.B. Saunders Company; 2001:109-148.Google Scholar
  38. 38.
    Woody CM, Lesher JL. Antimicrobial drugs. In: Bolognia JL, Jorizzo JL, Rapini RP, eds.Dermatology. 2nd ed. St. Louis, MO: Mosby Elsevier; 2008:2007-2032.Google Scholar
  39. 39.
    Zelickson BD. Mechanism of action of topical aminolevulinic acid. In: Goldman MP, ed.Photodynamic Therapy. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2008:1-9.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Sima Jain
    • 1
    • 2
  1. 1.College of Medicine Private PracticeAssistant Clinical Professor of Dermatology University of Illinois at ChicagoWest DundeeUSA
  2. 2.OrlandoUSA

Personalised recommendations